Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL

International Journal of Hematology-Oncology and Stem Cell Research

Guido Lancman¹  Janice Gabrilove²  Amir Steinberg² 

[1] Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA;Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA;

关键词: Serpentine supravenous hyperpigmentation;    SSH;    Chemotherapy;    R- CHOP;    DLBCL;   

DOI  :  

来源: DOAJ

【 摘 要 】

Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU1-3,but also seen with docetaxel4,5, fotemustine6, and vinorelbine7. It consists of a marked hyperpigmentation along the superficial network of veins proximal to the chemotherapy infusion site and was originally described in a 1976 case report in association with 5-FU1. Here, for the first time, we report SSH in association with R-CHOP chemotherapy

【 授权许可】

Unknown